Role of Soy Supplementation in Prostate Cancer Development
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This is a randomized study evaluating the effectiveness and direct effect a commercial soy
supplement has on prostate cancer and normal prostate tissue. Patient will be randomized it
either receive placebo or a commercial soy supplement for 2-4 weeks prior to the planned
surgery for treatment of their prostate cancer. Patient's blood and prostate tissue will be
evaluated to determine the effects of the soy supplement on the prostate tissue.